• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ITPKC 和 CASP3 多态性与川崎病免疫球蛋白静脉注射无反应和冠状动脉损伤形成的风险。

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

机构信息

Laboratory for Cardiovascular Diseases, Center for Genomic Medicine RIKEN, Yokohama, Kanagawa, Japan.

出版信息

Pharmacogenomics J. 2013 Feb;13(1):52-9. doi: 10.1038/tpj.2011.45. Epub 2011 Oct 11.

DOI:10.1038/tpj.2011.45
PMID:21987091
Abstract

Functional single-nucleotide polymorphisms (SNPs) in inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) (rs28493229) and caspase-3 (CASP3) (rs113420705; formerly rs72689236) are associated with susceptibility to Kawasaki's disease (KD). To evaluate the involvement of these 2 SNPs in the risk for intravenous immunoglobulin (IVIG) unresponsiveness, we investigated 204 Japanese KD patients who received a single IVIG dose of 2 g kg(-1) (n=70) or 1 g kg(-1) daily for 2 days (n=134). The susceptibility allele of both SNPs showed a trend of overrepresentation in IVIG non-responders and, in combined analysis of these SNPs, patients with at least 1 susceptible allele at both loci had a higher risk for IVIG unresponsiveness (P=0.0014). In 335 prospectively collected KD patients who were treated with IVIG (2 g kg(-1)), this 2-locus model showed a more significant association with resistance to initial and additional IVIG (P=0.011) compared with individual SNPs. We observed a significant association when all KD patients with coronary artery lesions were analyzed with the 2-locus model (P=0.0031). Our findings strongly suggest the existence of genetic factors affecting patients' responses to treatment and the risk for cardiac complications, and provide clues toward understanding the pathophysiology of KD inflammation.

摘要

功能性单核苷酸多态性(SNPs)在肌醇 1,4,5-三磷酸 3-激酶 C(ITPKC)(rs28493229)和半胱氨酸蛋白酶-3(CASP3)(rs113420705;以前称为 rs72689236)与川崎病(KD)的易感性有关。为了评估这两个 SNPs 是否与静脉注射免疫球蛋白(IVIG)无反应有关,我们研究了 204 名接受单次 2g/kg(n=70)或 1g/kg 每日 2 天(n=134)IVIG 剂量的日本 KD 患者。两个 SNP 的易感等位基因在 IVIG 无反应者中表现出过度表达的趋势,并且在这些 SNP 的联合分析中,两个位点至少有一个易感等位基因的患者 IVIG 无反应的风险更高(P=0.0014)。在 335 名接受 IVIG(2g/kg)治疗的前瞻性 KD 患者中,与个体 SNP 相比,该 2 个基因座模型与初始和额外 IVIG 的耐药性具有更显著的相关性(P=0.011)。当所有伴有冠状动脉病变的 KD 患者均采用 2 个基因座模型进行分析时,我们观察到了显著的相关性(P=0.0031)。我们的研究结果强烈表明存在影响患者对治疗反应和心脏并发症风险的遗传因素,并为理解 KD 炎症的病理生理学提供了线索。

相似文献

1
ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.ITPKC 和 CASP3 多态性与川崎病免疫球蛋白静脉注射无反应和冠状动脉损伤形成的风险。
Pharmacogenomics J. 2013 Feb;13(1):52-9. doi: 10.1038/tpj.2011.45. Epub 2011 Oct 11.
2
A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.在川崎病静脉注射免疫球蛋白无反应性和冠状动脉病变的 ITPCK 和 CASP3 双基因座分析中进行的复制研究。
PLoS One. 2013 Jul 24;8(7):e69685. doi: 10.1371/journal.pone.0069685. Print 2013.
3
[Association study of a functional SNP rs28493229 of ITPKC gene and Kawasaki disease in a Chinese population].[ITPKC基因功能性单核苷酸多态性rs28493229与中国人群川崎病的关联研究]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Dec;28(6):644-8. doi: 10.3760/cma.j.issn.1003-9406.2011.06.010.
4
Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population.ITPKC基因3'非翻译区的单核苷酸多态性rs2290692与汉族人群川崎病易感性相关。
Pediatr Cardiol. 2012 Oct;33(7):1046-53. doi: 10.1007/s00246-012-0223-x. Epub 2012 Feb 24.
5
Association of ITPKC gene polymorphisms rs28493229 and rs2290692 in North Indian children with Kawasaki disease.印度北部儿童川崎病与 ITPKC 基因多态性 rs28493229 和 rs2290692 的关联。
Pediatr Res. 2022 Oct;92(4):1090-1098. doi: 10.1038/s41390-021-01830-x. Epub 2021 Dec 24.
6
[Association of CASP3 gene single nucleotide polymorphisms with Kawasaki disease in Chinese children patients].[中国儿童患者中CASP3基因单核苷酸多态性与川崎病的关联]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Apr;30(2):180-4. doi: 10.3760/cma.j.issn.1003-9406.2013.04.013.
7
CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children.CASP3 基因单核苷酸多态性(rs72689236)与台湾儿童川崎病的关系。
J Hum Genet. 2011 Feb;56(2):161-5. doi: 10.1038/jhg.2010.154. Epub 2010 Dec 16.
8
ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.韩国川崎病患者中ITPKC和SLC11A1基因多态性及基因-基因相互作用
Yonsei Med J. 2018 Jan;59(1):119-127. doi: 10.3349/ymj.2018.59.1.119.
9
HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.HMGB1 基因多态性与川崎病冠状动脉病变及静脉注射免疫球蛋白抵抗相关。
Rheumatology (Oxford). 2019 May 1;58(5):770-775. doi: 10.1093/rheumatology/key356.
10
A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.日本静脉注射免疫球蛋白治疗无反应性川崎病患者低频 IL4R 基因座变异。
Pediatr Rheumatol Online J. 2019 Jul 3;17(1):34. doi: 10.1186/s12969-019-0337-2.

引用本文的文献

1
A comprehensive integration of data on the association of ITPKC polymorphisms with susceptibility to Kawasaki disease: a meta-analysis.ITPKC基因多态性与川崎病易感性关联的数据综合分析:一项荟萃分析
BMC Med Genomics. 2025 Mar 20;18(1):56. doi: 10.1186/s12920-025-02121-8.
2
Kawasaki Disease-Associated Cytokine Storm Syndrome.川崎病相关细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:365-383. doi: 10.1007/978-3-031-59815-9_25.
3
Subsequent development of Kawasaki disease following acute human adenovirus infection among siblings.
兄弟姐妹中急性人腺病毒感染后继发川崎病。
BMJ Case Rep. 2024 Jan 24;17(1):e257257. doi: 10.1136/bcr-2023-257257.
4
Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment.重症川崎病冠状动脉异常及对免疫球蛋白加环孢素A治疗耐药的危险因素:KAICA试验的亚组分析,环孢素A作为一线治疗的随机试验
Front Pediatr. 2023 Dec 15;11:1321533. doi: 10.3389/fped.2023.1321533. eCollection 2023.
5
[Research advances in genetic polymorphisms in Kawasaki disease].[川崎病基因多态性的研究进展]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Dec 15;25(12):1234-1238. doi: 10.7499/j.issn.1008-8830.2308073.
6
polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population.在南方汉族人群中,川崎病患者的多态性(rs7251246 T > C)、冠状动脉瘤和血栓形成。
Front Immunol. 2023 Jun 19;14:1184162. doi: 10.3389/fimmu.2023.1184162. eCollection 2023.
7
Central and Peripheral Nervous System Complications of Vasculitis Syndromes from Pathology to Bedside: Part 2-Peripheral Nervous System.血管炎综合征的中枢和周围神经系统并发症:从病理学到床边:第 2 部分-周围神经系统。
Curr Neurol Neurosci Rep. 2023 Mar;23(3):83-107. doi: 10.1007/s11910-023-01249-3. Epub 2023 Feb 23.
8
Increased Myosin light chain 9 expression during Kawasaki disease vasculitis.川崎病血管炎时肌球蛋白轻链 9 表达增加。
Front Immunol. 2023 Jan 6;13:1036672. doi: 10.3389/fimmu.2022.1036672. eCollection 2022.
9
MicroRNAs in Kawasaki disease: An update on diagnosis, therapy and monitoring.川崎病相关 microRNAs:诊断、治疗和监测的新进展。
Front Immunol. 2022 Oct 24;13:1016575. doi: 10.3389/fimmu.2022.1016575. eCollection 2022.
10
The possible association between epidemics of hand-foot-and-mouth disease and responsiveness to immunoglobulin therapy in Kawasaki disease.手足口病流行与川崎病免疫球蛋白治疗反应之间的可能关联。
Front Pediatr. 2022 Sep 6;10:968857. doi: 10.3389/fped.2022.968857. eCollection 2022.